Silencing of LncRNA PVT1 inhibits the proliferation, migration and fibrosis of high glucose-induced mouse mesangial cells via targeting microRNA-93-5p.

LncRNA-PVT1 PI3K/Akt/mTOR pathway diabetic nephropathy miR-93-5p mouse mesangial cells

Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 06 01 2020
revised: 16 04 2020
accepted: 20 04 2020
pubmed: 25 4 2020
medline: 25 4 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

The present study aimed to investigate the regulatory role of long non-coding RNA plasmacytoma variant translocation 1 (PVT1) on high glucose (HG)-induced mouse mesangial cells (MMCs). PVT1 expression in diabetic nephropathy (DN) mice and HG-induced MMCs was detected by qRT-PCR. EdU and Colony formation, Annexin V-PI staining, Muse cell cycle, Scratch, and Transwell assays were performed to detect the cell proliferation, apoptosis, cell cycle, migration, and invasion, respectively. The contents of fibrosis factors in cell-culture supernatants were detected by enzyme-linked immunosorbent assay (ELISA). Western blot was performed to detect the expression of factors involved in apoptosis, cell cycle, migration and invasion, fibrosis, and PI3K/Akt/mTOR pathway. The targeting relation between miR-93-5p and PVT1 was predicted by StarBase3.0 (an online software for analyzing the targeting relationship) and identified by Dual-luciferase reporter (DLR) assay. PVT1 was overexpressed in DN kidney tissues and HG-induced MMCs. HG-induced MMCs exhibited significantly increased EdU-positive cells, cell colonies, S and G2/M phase cells, migration and invasion ability, and contents of fibrosis factors, as well as significantly decreased apoptosis rate compared with NG-induced MMCs. HG significantly up-regulated Bcl-2, CyclinD1, CDK4, N-cadherin, vimentin, Col. IV, FN, TGF-β1 and PAI-1, and down-regulated Bax, cleaved caspase-3, cleaved PARP, and E-cadherin in MMCs. Silencing of PVT1 eliminated the effects of HG in MMCs and blocked PI3K/Akt/mTOR pathway. MiR-93-5p was a target of PVT1, which eliminated the effects of PVT1 on HG-induced MMCs. PVT1 silencing inhibited the proliferation, migration, invasion and fibrosis, promoted the apoptosis, and blocked PI3K/Akt/mTOR pathway in HG-induced MMCs via up-regulating miR-93-5p.

Identifiants

pubmed: 32329508
pii: 222762
doi: 10.1042/BSR20194427
pmc: PMC7199453
pii:
doi:

Types de publication

Journal Article Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : RetractionIn

Informations de copyright

© 2020 The Author(s).

Références

Sci Rep. 2016 Mar 31;6:23884
pubmed: 27029904
Cell. 2010 Oct 1;143(1):46-58
pubmed: 20887892
Mol Cell Endocrinol. 2016 May 5;426:136-45
pubmed: 26923441
J Endocrinol. 2015 Jan;224(1):R15-30
pubmed: 25349246
Biochem Biophys Res Commun. 2013 Apr 19;433(4):359-61
pubmed: 23541575
Oncol Lett. 2016 Mar;11(3):1745-1749
pubmed: 26998071
Oncotarget. 2016 Mar 8;7(10):11553-66
pubmed: 26872375
Oncogene. 2011 Apr 21;30(16):1956-62
pubmed: 21151178
Diabetes. 2007 Apr;56(4):975-83
pubmed: 17395743
J Cancer. 2017 Mar 7;8(5):870-879
pubmed: 28382150
Am J Transl Res. 2016 Nov 15;8(11):5025-5034
pubmed: 27904703
Nat Commun. 2016 Jun 28;7:12076
pubmed: 27350436
Behav Brain Res. 2016 May 15;305:265-77
pubmed: 26971628
Kidney Int Suppl. 2005 Sep;(98):S69-75
pubmed: 16108975
PLoS One. 2013 Oct 25;8(10):e77468
pubmed: 24204837
J Pharmacol Sci. 2018 Apr;136(4):218-227
pubmed: 29551286
Expert Opin Investig Drugs. 2017 Jun;26(6):741-750
pubmed: 28468519
Oncol Rep. 2017 Oct;38(4):2408-2416
pubmed: 28791407
Oncotarget. 2015 Jun 20;6(17):14993-5007
pubmed: 25915427
Cell Physiol Biochem. 2017;41(3):1035-1043
pubmed: 28222433
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6929-35
pubmed: 25400777
Cancer Res. 2011 Jun 1;71(11):3852-62
pubmed: 21558391
J Cell Physiol. 2018 May;233(5):4044-4055
pubmed: 28657147
PLoS One. 2011 Apr 22;6(4):e18671
pubmed: 21526116
Endocrine. 2016 Oct;54(1):81-92
pubmed: 27083175
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1159-1166
pubmed: 28382439
Diabetes. 2007 Dec;56(12):3027-32
pubmed: 17881614
J Med Chem. 2017 Nov 9;60(21):8847-8857
pubmed: 28994286
J Cell Mol Med. 2017 Nov;21(11):2732-2747
pubmed: 28444861
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Mol Cancer Res. 2008 Feb;6(2):212-21
pubmed: 18314482
J Clin Invest. 2012 Nov;122(11):3990-4002
pubmed: 23093776
Cell Physiol Biochem. 2018;46(2):591-608
pubmed: 29617692
J Biol Chem. 2010 Jul 23;285(30):23457-65
pubmed: 20501654
J Histochem Cytochem. 2013 Jun;61(6):433-43
pubmed: 23456824
Saudi J Kidney Dis Transpl. 2006 Dec;17(4):481-90
pubmed: 17186681
Sci Rep. 2017 Jun 23;7(1):4145
pubmed: 28646178
Phytomedicine. 2015 Nov 15;22(12):1071-8
pubmed: 26547529
Diabetologia. 2013 Mar;56(3):444-56
pubmed: 23135222
Exp Ther Med. 2017 Feb;13(2):581-587
pubmed: 28352334

Auteurs

Jianzhou Li (J)

Department of Endocrinology, Caoxian People's Hospital, East Qinghe Road, South Fumin Avenue, Caoxian Development Zone, Heze City 274400, Shandong Province, China.

Qing Zhao (Q)

Department of Endocrinology, Caoxian People's Hospital, East Qinghe Road, South Fumin Avenue, Caoxian Development Zone, Heze City 274400, Shandong Province, China.

Xiaohong Jin (X)

Department of Endocrinology, Caoxian People's Hospital, East Qinghe Road, South Fumin Avenue, Caoxian Development Zone, Heze City 274400, Shandong Province, China.

Yanhua Li (Y)

Department of Medical, First People's Hospital of Jinan City, No. 132, Daminghu Road, Lixia District, Jinan City 250011, Shandong Province, China.

Jian Song (J)

Department of Nephrology, Qilu Hospital of Shandong University, No. 107, Wenhua West Road, Jinan City 250012, Shandong Province, China.

Classifications MeSH